BONESUPPORTs annual report for 2018 is now available as a pdf on the group’s web page, www.bonesupport.com. A PDF-version is also attached to this press release.   About BONESUPPORT™ BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative inj... read more

GS010-treated eyes showed continuous recovery of visual functions from nadir (worst vision post-treatment) in both best-corrected visual acuity (BCVA) and contrast sensitivity (CS) GS010-treated eyes recovered 21 ETDRS letters from nadir at Week 72 Bilateral improvements in visual function... read more

April 16, 2019—BOSTON, MA. and STOCKHOLM, SWEDEN, April 16, 2019 – Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced that the U.S. Food and Drug Administration (FDA) has... read more

DUBLIN, Ireland and TREVOSE, Pa., April 15, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet nee... read more

Mölndal, April 12, 2019 - Vicore Pharma Holding AB (publ) announces today that the annual report for 2018 has been published and is available on the company's website: https://vicorepharma.com/investors/#reports The annual report shows that the publication date for the interim report quarter th... read more